These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Imatinib assay by high-performance liquid chromatography in tandem mass spectrometry with solid-phase extraction in human plasma. Moreno JM, Wojnicz A, Steegman JL, Cano-Abad MF, Ruiz-Nuño A. Biomed Chromatogr; 2013 Apr; 27(4):502-8. PubMed ID: 23034891 [Abstract] [Full Text] [Related]
3. Quantification of imatinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry. Titier K, Picard S, Ducint D, Teilhet E, Moore N, Berthaud P, Mahon FX, Molimard M. Ther Drug Monit; 2005 Oct; 27(5):634-40. PubMed ID: 16175138 [Abstract] [Full Text] [Related]
5. A new HPLC-UV validated method for therapeutic drug monitoring of tyrosine kinase inhibitors in leukemic patients. Pirro E, De Francia S, De Martino F, Fava C, Ulisciani S, Cambrin GR, Racca S, Saglio G, Di Carlo F. J Chromatogr Sci; 2011 Oct; 49(10):753-7. PubMed ID: 22080802 [Abstract] [Full Text] [Related]
12. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry. Haouala A, Zanolari B, Rochat B, Montemurro M, Zaman K, Duchosal MA, Ris HB, Leyvraz S, Widmer N, Decosterd LA. J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul 15; 877(22):1982-96. PubMed ID: 19505856 [Abstract] [Full Text] [Related]
13. Simultaneous measurement of imatinib, nilotinib and dasatinib in dried blood spot by ultra high performance liquid chromatography tandem mass spectrometry. Kralj E, Trontelj J, Pajič T, Kristl A. J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug 15; 903():150-6. PubMed ID: 22857863 [Abstract] [Full Text] [Related]
14. Quantitative determination of imatinib in human plasma with high-performance liquid chromatography and ultraviolet detection. Miura M, Takahashi N, Sawada K. J Chromatogr Sci; 2011 May 15; 49(5):412-5. PubMed ID: 21549035 [Abstract] [Full Text] [Related]
15. Bioequivalence study of 400 and 100 mg imatinib film-coated tablets in healthy volunteers. Ostrowicz A, Mikołajczak PL, Wierzbicka M, Boguradzki P. Acta Pol Pharm; 2014 May 15; 71(5):843-54. PubMed ID: 25362813 [Abstract] [Full Text] [Related]
16. Simultaneous quantitation of azole antifungals, antibiotics, imatinib, and raltegravir in human plasma by two-dimensional high-performance liquid chromatography-tandem mass spectrometry. Jourdil JF, Tonini J, Stanke-Labesque F. J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar 01; 919-920():1-9. PubMed ID: 23384531 [Abstract] [Full Text] [Related]
17. Development and validation of an high performance liquid chromatography-tandem mass spectrometry method for the determination of imatinib in rat tissues. Bianchi F, Caffarri E, Cavalli S, Lagrasta C, Musci M, Quaini F, Savi M. J Pharm Biomed Anal; 2013 Jan 25; 73():103-7. PubMed ID: 22709608 [Abstract] [Full Text] [Related]
18. Validation of an HPLC method for determination of imatinib mesylate in rat serum and its application in a pharmacokinetic study. Bende G, Kollipara S, Movva S, Moorthy G, Saha R. J Chromatogr Sci; 2010 Jan 25; 48(5):334-41. PubMed ID: 20515524 [Abstract] [Full Text] [Related]
20. Liquid chromatographic-mass spectrometric assay for quantitation of imatinib and its main metabolite (CGP 74588) in plasma. Parise RA, Ramanathan RK, Hayes MJ, Egorin MJ. J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul 05; 791(1-2):39-44. PubMed ID: 12798163 [Abstract] [Full Text] [Related] Page: [Next] [New Search]